The dynamic nature of the K-Ras/calmodulin complex can be altered by oncogenic mutations

被引:11
|
作者
Abdelkarim, Hazem [1 ]
Leschinsky, Nicholas [1 ]
Jang, Hyunbum [2 ]
Banerjee, Avik [3 ]
Nussinov, Ruth [2 ,4 ]
Gaponenko, Vadim [1 ]
机构
[1] Univ Iinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA
[2] Natl Canc Inst, Frederick Natl Lab Canc Res, Computat Struct Biol Sect, Lab Canc Immunometabolism, Frederick, MD 21702 USA
[3] Univ Georgia, Coll Vet Med, Ctr Vaccines & Immunol, Athens, GA 30602 USA
[4] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel
基金
美国国家卫生研究院;
关键词
SMALL GTPASE K-RAS4B; MEMBRANE-BINDING; HYPERVARIABLE REGION; RAS; CALMODULIN; KRAS; PHOSPHORYLATION; PROTEIN; DOMAIN; IDENTIFICATION;
D O I
10.1016/j.sbi.2021.06.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oncogenic mutant K-Ras promotes cancer cell proliferation, migration, invasion, and survival by assembling signaling complexes. To date, the functional and structural roles of K-Ras mutations within these complexes are incompletely understood despite their mechanistic and therapeutic significance. Here, we review recent advances in understanding specific binding between K-Ras and the calcium sensor calmodulin. This interaction positively and negatively regulates diverse functions of K-Ras in cancer, suggesting flexibility in K-Ras/calmodulin complex formation. Also, structural data suggest that oncogenic K-Ras likely samples several conformational states, influencing its distinct assemblies with calmodulin and with other proteins. Understanding how K-Ras interacts with calmodulin and with other partners is essential to discovering novel inhibitors of K-Ras in cancer.
引用
收藏
页码:164 / 170
页数:7
相关论文
共 50 条
  • [1] Physiological analysis of oncogenic K-Ras
    Perez-Mancera, Pedro Antonio
    Tuveson, David A.
    REGULATORS AND EFFECTORS OF SMALL GTPASES: RAS FAMILY, 2006, 407 : 676 - +
  • [2] The molecular nature of K-Ras mutations influences the angiogenic tumor phenotype
    Arbos Via, Maria Antonia
    Quiles, M. T.
    Figueras, A.
    Mangues, R.
    Vinals, F.
    Germa, J. R.
    Capella, G.
    INFLAMMATION RESEARCH, 2007, 56 : S463 - S463
  • [3] Oncogenic K-ras "addiction" and synthetic lethality
    Singh, Anurag
    Settleman, Jeff
    CELL CYCLE, 2009, 8 (17) : 2676 - 2677
  • [4] Modeling and subtleties of K-Ras and Calmodulin interaction
    Garrido, Eduardo
    Lazaro, Juan
    Jaumot, Montserrat
    Agell, Neus
    Rubio-Martinez, Jaime
    PLOS COMPUTATIONAL BIOLOGY, 2018, 14 (10)
  • [5] K-ras mutations in pancreatic cancer
    Grady, M
    Gaut, A
    Liu, JR
    Zhang, YP
    Zhang, H
    Weydert, C
    Domann, F
    Oberley, L
    Cullen, J
    FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 : S440 - S440
  • [6] K-ras Mutations in Hepatocellular Carcinomas
    Liu, C.
    Cardona, D.
    Dong, H. J.
    LABORATORY INVESTIGATION, 2010, 90 : 363A - 363A
  • [7] K-ras Mutations in Hepatocellular Carcinomas
    Liu, C.
    Cardona, D.
    Dong, H. J.
    MODERN PATHOLOGY, 2010, 23 : 363A - 363A
  • [8] Identification of essential interacting elements in K-Ras/calmodulin binding and its role in K-Ras localization
    Lopez-Alcala, Cristina
    Alvarez-Moya, Blanca
    Villalonga, Priam
    Calvo, Maria
    Bachs, Oriol
    Agell, Neus
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (16) : 10621 - 10631
  • [9] Acute sensitivity of the oral mucosa to oncogenic K-ras
    van der Weyden, Louise
    Alcolea, Maria P.
    Jones, Philip H.
    Rust, Alistair G.
    Arends, Mark J.
    Adams, David J.
    JOURNAL OF PATHOLOGY, 2011, 224 (01): : 22 - 32
  • [10] Oncogenic K-Ras suppresses global miRNA function
    Shui, Bing
    Beyett, Tyler S.
    Chen, Zhengyi
    Li, Xiaoyi
    Rocca, Gaspare La
    Gazlay, William M.
    Eck, Michael J.
    Lau, Ken S.
    Ventura, Andrea
    Haigis, Kevin M.
    MOLECULAR CELL, 2023, 83 (14) : 2509 - +